BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 34334405)

  • 1. Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer's Disease Mice.
    Watson Y; Nelson B; Kluesner JH; Tanzy C; Ramesh S; Patel Z; Kluesner KH; Singh A; Murthy V; Mitchell CS
    J Alzheimers Dis; 2021; 83(1):435-450. PubMed ID: 34334405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
    Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
    Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
    Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
    Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
    Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
    Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of APOE genotype on prion-type propagation of tauopathy.
    Williams T; Ruiz AJ; Ruiz AM; Vo Q; Tsering W; Xu G; McFarland K; Giasson BI; Sullivan P; Borchelt DR; Chakrabarty P
    Acta Neuropathol Commun; 2022 Apr; 10(1):57. PubMed ID: 35440098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.
    Hartman RE; Wozniak DF; Nardi A; Olney JW; Sartorius L; Holtzman DM
    Exp Neurol; 2001 Aug; 170(2):326-44. PubMed ID: 11476599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Chronic Cadmium Exposure on Brain and Liver Transporters and Drug-Metabolizing Enzymes in Male and Female Mice Genetically Predisposed to Alzheimer's Disease.
    Wang H; Zhang L; Xia Z; Cui JY
    Drug Metab Dispos; 2022 Oct; 50(10):1414-1428. PubMed ID: 35878927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
    Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
    Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice.
    East BS; Fleming G; Peng K; Olofsson JK; Levy E; Mathews PM; Wilson DA
    Neuroscience; 2018 Jun; 380():103-110. PubMed ID: 29678753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein e genotype-dependent paradoxical short-term effects of (56)fe irradiation on the brain.
    Haley GE; Villasana L; Dayger C; Davis MJ; Raber J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):793-9. PubMed ID: 22401921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential and substrate-specific inhibition of γ-secretase by the C-terminal region of ApoE2, ApoE3, and ApoE4.
    Hou X; Zhang X; Zou H; Guan M; Fu C; Wang W; Zhang ZR; Geng Y; Chen Y
    Neuron; 2023 Jun; 111(12):1898-1913.e5. PubMed ID: 37040764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
    Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
    Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice.
    Sharman MJ; Morici M; Hone E; Berger T; Taddei K; Martins IJ; Lim WL; Singh S; Wenk MR; Ghiso J; Buxbaum JD; Gandy S; Martins RN
    J Alzheimers Dis; 2010; 21(2):403-9. PubMed ID: 20555142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE genotype alters glial activation and loss of synaptic markers in mice.
    Zhu Y; Nwabuisi-Heath E; Dumanis SB; Tai LM; Yu C; Rebeck GW; LaDu MJ
    Glia; 2012 Apr; 60(4):559-69. PubMed ID: 22228589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE2 Exacerbates TDP-43 Related Toxicity in the Absence of Alzheimer Pathology.
    Meneses AD; Koga S; Li Z; O'Leary J; Li F; Chen K; Murakami A; Qiao W; Kurti A; Heckman MG; White L; Xie M; Chen Y; Finch NA; Lim MJ; Delenclos M; DeTure MA; Linares C; Martin NB; Ikezu TC; van Blitterswijk MM; Wu LJ; McLean PJ; Rademakers R; Ross OA; Dickson DW; Bu G; Zhao N
    Ann Neurol; 2023 Apr; 93(4):830-843. PubMed ID: 36546684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.